Skip to main content

Advertisement

SpringerLink
Log in

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Expression of thymidylate synthase (TS) and the 5-fluorouracil (5-FU) metabolic enzymes, including dihydropyrimidine dehydrogenase (DPD), orotate phosphoribosyl transferase (OPRT), thymidine phosphorylase (TP), and uridine phosphorylase (UP), has been reported to be associated with the sensitivity to 5-FU-based chemotherapy in colorectal cancer. We evaluated the correlation of the expression of these genes between primary tumors and corresponding liver metastases.

Method

The mRNA levels of TS, DPD, OPRT, TP, and UP were measured by real-time quantitative RT-PCR in samples from 23 consecutive patients with both primary colorectal adenocarcinoma and liver metastasis.

Results

The DPD, OPRT, TP, and UP mRNA levels were significantly higher in liver metastases than in primary tumor (expression in relation to that of β-actin mRNA: 0.42 vs 0.16, P=0.00053; 1.4 vs 0.92, P=0.016; 23 vs 11, P=0.00014; 0.36 vs 0.25, P=0.0026; respectively). However, the TS mRNA level did not differ significantly between liver metastases than primary tumor (0.20 vs 0.16, P=0.28). No correlation was observed for any gene between primary tumor and liver metastases. In both primary tumor and liver metastasis, the TS mRNA levels correlated significantly with the OPRT mRNA level (primary r S=0.83, P=0.00000081; liver metastasis r S=0.49, P=0.017), while the DPD mRNA level correlated significantly with the TP mRNA level r S=0.81, P=0.0000024; r S=0.63, P=0.0014; respectively).

Conclusions

The differential gene expression of 5-FU metabolic enzymes between primary colorectal cancer and corresponding liver metastases should be taken into consideration when estimating the sensitivity to 5-FU-based chemotherapy in colorectal cancer. The gene expression of TS and OPRT, which are involved in de novo pyrimidine synthesis, and that of DPD and TP, may be coregulated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–e
Fig. 2a, b
Fig. 3a, b

Similar content being viewed by others

References

  1. Allegra CJ, Parr AL, Wold LE, Mahoney MR, Sargent DJ, Johnston P, Klein P, Behan K, O’Connell MJ, Levitt R, Kugler JW, Tirona MT, Goldberg RM (2002) Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J Clin Oncol 20:1735

    Article  CAS  PubMed  Google Scholar 

  2. Aschele C, Debernardis D, Casazza S, Antonelli G, Tunesi G, Baldo C, Lionetto R, Maley F, Sobrero A (1999) Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol 17:1760

    CAS  PubMed  Google Scholar 

  3. Beck A, Etienne MC, Chéradame S, Fischel JL, Formento P, Renée N, Milano G (1994) A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 30A:1517

    CAS  PubMed  Google Scholar 

  4. Bièche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999) Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res 59:2759

    CAS  PubMed  Google Scholar 

  5. Cascinu S, Aschele C, Barni S, Dabernardis D, Baldo C, Tunesi G, Catalano V, Staccioli MP, Brenna A, Muretto P, Catalano G (1999) Thymidylate synthase protein expression in advanced colorectal cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Clin Cancer Res 5:1996

    CAS  PubMed  Google Scholar 

  6. Chung YM, Park SH, Park JK, Kim YT, Kang YK, Yoo YD (2000) Establishment and characterization of 5-fluorouracil-resistent gastric cancer cells. Cancer Lett 159:95

    Article  CAS  PubMed  Google Scholar 

  7. Collie-Duguid ESR, Johmston SJ, Boyce L, Smith N, Cowieson A, Cassidy J, Murray GI, Mcleod H (2001) Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer. Int J Cancer 94:297

    Article  CAS  PubMed  Google Scholar 

  8. Cuq P, Rouquet C, Evrard V, Ciccolini J, Vian L, Cano JP (2001) Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase. Br J Cancer 84:1677

    Article  CAS  PubMed  Google Scholar 

  9. Davies MM, Johnston PG, Kaur S, Allen-Mersh TG (1999) Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. Clin Cancer Res 5:325

    CAS  PubMed  Google Scholar 

  10. Edler D, Glimelius B, Hallstörm M, Jakobsen A, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H (2002) Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 20:1721

    Article  CAS  PubMed  Google Scholar 

  11. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F, Milano G (1995) Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13:1663

    CAS  PubMed  Google Scholar 

  12. Evrard A, Cuq P, Robert B, Vian L, Pélegrin A, Cano JP (1999) Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study. Int J Cancer 80:465

    CAS  PubMed  Google Scholar 

  13. Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K (2002) Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. Int J Cancer 99:328

    Article  PubMed  Google Scholar 

  14. Fukushima M, Nomura H, Murakami Y, Shirasaka T, Aiba K (1996) Estimation of pathway of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo. Jpn J Cancer Chemother 23:721

    CAS  Google Scholar 

  15. Heid CA, Stevenes J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986

    CAS  PubMed  Google Scholar 

  16. Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S, Wada H (2000) Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy. Int J Oncol 17:47

    CAS  PubMed  Google Scholar 

  17. Ichikawa W, Uetake H, Shirota Y, Yamada H, Nishi N, Nihei Z, Sugihara K, Hirayama R (2003) Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Clin Cancer Res 9:786

    CAS  PubMed  Google Scholar 

  18. Inaba M, Mitsuhashi J, Sawada H, Miike N, Naoe Y, Daimon A, Koizumi K, Tsujimoto H, Fukushima M (1996) Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn J Cancer Res 87:212

    CAS  PubMed  Google Scholar 

  19. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M (2000) Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil. Jpn J Cancer Res 91:105

    CAS  PubMed  Google Scholar 

  20. Johnston PG, Lenz HJ, Leichman, CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L (1995) Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55:1407

    CAS  PubMed  Google Scholar 

  21. Johnston SJ, Ridge SA, Cassidy J, McLeod HL (1999) Regulation of dihydropyrimidine dehydrogenase in colorectal cancer. Clin Cancer Res 5:2566

    Google Scholar 

  22. Kanzaki A, Takebayshi Y, Bando H, Eliason JF, Watanabe S, Miyashita H, Fukumoto M, Toi M, Uchida T (2002) Expression of uridine and thymidine phosphorylase genes in human breast carcinoma. Int J Cancer 97:631

    Article  CAS  PubMed  Google Scholar 

  23. Kasahara M, Takahashi Y, Nagata T, Asai S, Eguchi T, Ishii Y, Fujii M, Ishikawa K (2000) Thymidylate synthase expression correlates closely with E2F1 expression in colorectal cancer. Clin Cancer Res 6:2707

    CAS  PubMed  Google Scholar 

  24. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15:3223

    CAS  PubMed  Google Scholar 

  25. Mader RM, Sieder AE, Braun J, Rizovski B, Kalipciyan M, Mueller MW, Jakesz R, Rainer H, Steger GG (1997) Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro. Biochem Pharmacol 54:1233

    Google Scholar 

  26. Maehara Y, Moriguchi S, Emi Y, Watanabe A, Kohnoe S, Tsujitani S, Sugimachi K (1990) Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer 66:156

    CAS  PubMed  Google Scholar 

  27. Marchetti S, Chazal M, Dubreuil A, Fischel JL, Etienne MC, Milano G (2001) Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumor angiogenesis. Br J Cancer 85:439

    Article  CAS  PubMed  Google Scholar 

  28. Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV (1998) High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 4:2371

    CAS  PubMed  Google Scholar 

  29. Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ, Johnston PG (2000) Thymidylate synthase and p53 primary tumor expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560

    Article  CAS  PubMed  Google Scholar 

  30. Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM (1986) Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res 46:20

    CAS  PubMed  Google Scholar 

  31. Peters GJ, Braakhuis BJ, de Bruijn EA, Laurensse EJ, van Walsum M, Pinedo HM (1989) Enhanced therapeutic efficacy of 5′-deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumors in relation to 5-fluorouracil metabolizing enzymes. Br J Cancer 59:327

    CAS  PubMed  Google Scholar 

  32. Peters GJ, van Groeningen CJ, Laurensse EJ, Pinedo HM (1991) A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa. Cancer 68:1903

    CAS  Google Scholar 

  33. Salonga D, Danenberg KD, Johnston M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV (2000) Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322

    CAS  PubMed  Google Scholar 

  34. Schwartz EL, Baptiste N, Wadler S, Makower D (1995) Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270:19073

    CAS  PubMed  Google Scholar 

  35. Schwartz PM, Moir RD, Hyde CM, Turek PJ, Handschumacher RE (1985) Role of uridine phosphorylase in the anabolism of 5-fluorouracil. Biochem Pharmacol 34:3585

    Google Scholar 

  36. Shirota Y, Ichikawa W, Uetake H, Yamada H, Nihei Z, Sugihara K (2002) Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer. Ann Surg Oncol 9:599

    Article  PubMed  Google Scholar 

  37. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F, Aikou T (1996) Clinicopathological and prognostic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88:1110

    CAS  PubMed  Google Scholar 

  38. Uetake H, Ichikawa W, Takechi T, Fukushima M, Nihei Z, Sugihara K (1999) Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer. Clin Cancer Res 5:2836

    CAS  PubMed  Google Scholar 

  39. Yamada H, Ichikawa W, Uetake H, Shirota Y, Nihei Z, Sugihara K, Hirayama R (2001) Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites. Clin Colorectal Cancer 1:169

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Digestive Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, 113-8519 Bunkyo-ku, Tokyo, Japan

    Mikito Inokuchi, Hiroyuki Uetake, Yoshinori Shirota, Hiroyuki Yamada, Masayuki Tajima & Kenichi Sugihara

Authors
  1. Mikito Inokuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Uetake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshinori Shirota
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masayuki Tajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenichi Sugihara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mikito Inokuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inokuchi, M., Uetake, H., Shirota, Y. et al. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Cancer Chemother Pharmacol 53, 391–396 (2004). https://doi.org/10.1007/s00280-003-0747-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-003-0747-0

Key words

Search

Navigation